Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 1
2002 1
2006 1
2007 1
2009 1
2011 2
2012 1
2013 1
2014 2
2016 4
2017 3
2018 3
2019 4
2020 5
2021 6
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Hill DA, Crider M, Hill SR. Hill DA, et al. Am Fam Physician. 2016 Dec 1;94(11):884-889. Am Fam Physician. 2016. PMID: 27929271 Free article. Review.
Patients with genitourinary syndrome of menopause may benefit from vaginal estrogen, nonhormonal vaginal moisturizers, or ospemifene (the only nonhormonal treatment approved by the U.S. ...The decision to use hormone therapy depends on clinical presentation,
Patients with genitourinary syndrome of menopause may benefit from vaginal estrogen, nonhormonal vaginal moisturizers,
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline.
Harkenrider MM, Abu-Rustum N, Albuquerque K, Bradfield L, Bradley K, Dolinar E, Doll CM, Elshaikh M, Frick MA, Gehrig PA, Han K, Hathout L, Jones E, Klopp A, Mourtada F, Suneja G, Wright AA, Yashar C, Erickson BA. Harkenrider MM, et al. Pract Radiat Oncol. 2023 Jan-Feb;13(1):41-65. doi: 10.1016/j.prro.2022.09.002. Epub 2022 Oct 22. Pract Radiat Oncol. 2023. PMID: 36280107
PURPOSE: With the results of several recently published clinical trials, this guideline informs on the use of adjuvant radiation therapy (RT) and systemic therapy in the treatment of endometrial cancer. ...Recommendations were based on a systematic literature review …
PURPOSE: With the results of several recently published clinical trials, this guideline informs on the use of adjuvant radiation ther …
Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT, Willson ML, Goel S, Beith J, Goodwin A. Bui KT, et al. Cochrane Database Syst Rev. 2020 Mar 6;3(3):CD013538. doi: 10.1002/14651858.CD013538. Cochrane Database Syst Rev. 2020. PMID: 32141074 Free PMC article.
Adding OFS to treatment likely reduces the risk of contralateral breast cancer (HR 0.75, 95% CI 0.57 to 0.97; 9 studies; 9138 women; moderate-certainty evidence). Quality of life was assessed in five studies; four studies used validated tools, and the fifth study provided …
Adding OFS to treatment likely reduces the risk of contralateral breast cancer (HR 0.75, 95% CI 0.57 to 0.97; 9 studies; 9138 women; …
Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review.
Cianci S, Tarascio M, Arcieri M, La Verde M, Martinelli C, Capozzi VA, Palmara V, Gulino F, Gueli Alletti S, Caruso G, Restaino S, Vizzielli G, Conte C, Palumbo M, Ercoli A. Cianci S, et al. Medicina (Kaunas). 2023 Apr 4;59(4):704. doi: 10.3390/medicina59040704. Medicina (Kaunas). 2023. PMID: 37109662 Free PMC article. Review.
Introduction: The aim of this study is to analyze the available scientific evidence regarding the quality of life (QoL) and sexual function (SF) in patients affected by cervical cancer (CC) after surgical and adjuvant treatments. ...This type of tailored therapeutic …
Introduction: The aim of this study is to analyze the available scientific evidence regarding the quality of life (QoL) and sexual function …
Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
Mendez LC, Weiss Y, D'Souza D, Ravi A, Barbera L, Leung E. Mendez LC, et al. Radiother Oncol. 2017 May;123(2):312-318. doi: 10.1016/j.radonc.2017.03.005. Epub 2017 Mar 25. Radiother Oncol. 2017. PMID: 28351521 Review.
RESULTS: A total of 672 cervical cancer patients were treated with P-ISBT and planned with 3D image-based planning. Clinical outcomes could be identified for 392 patients and 60% were staged IIIB or higher. Most patients received 45-50.4Gy EBRT to the …
RESULTS: A total of 672 cervical cancer patients were treated with P-ISBT and planned with 3D image-based planning. Clinical o …
Side effects and acceptability measures for thermal ablation as a treatment for cervical precancer in low-income and middle-income countries: a systematic review and meta-synthesis.
Piret EM, Payne BA, Smith LW, Trawin J, Orem J, Ogilvie G, Nakisige C. Piret EM, et al. Fam Med Community Health. 2022 May;10(2):e001541. doi: 10.1136/fmch-2021-001541. Fam Med Community Health. 2022. PMID: 35523456 Free PMC article. Review.
ELIGIBILITY CRITERIA: Studies that reported one or more side effects or patient acceptability measures after treatment of the cervix using TA in women living in LMICs who completed a cervical cancer screening test. ...No women discontinued treatment due to pain. At …
ELIGIBILITY CRITERIA: Studies that reported one or more side effects or patient acceptability measures after treatment of the cervix …
Contextual factors associated with uptake of breast and cervical cancer screening: A systematic review of the literature.
Plourde N, Brown HK, Vigod S, Cobigo V. Plourde N, et al. Women Health. 2016 Nov-Dec;56(8):906-25. doi: 10.1080/03630242.2016.1145169. Epub 2016 Jan 26. Women Health. 2016. PMID: 26812962 Review.
Thirteen studies met the inclusion criteria. Findings revealed a positive association between patients' receipt of provider recommendation and uptake of breast and cervical cancer screening. ...Similarly, greater organizational commitment to quality and performance …
Thirteen studies met the inclusion criteria. Findings revealed a positive association between patients' receipt of provider recommend …
Systematic Review of Comparisons Between Plastic and Silicone Dilators: Revealing a Knowledge Gap.
Morgan O, Lopez MD, Martinez AJC, Marshall DC, Schnur JB. Morgan O, et al. Sex Med Rev. 2022 Oct 1;10(4):513-519. doi: 10.1016/j.sxmr.2022.06.008. Sex Med Rev. 2022. PMID: 37051960
Dilator therapy is an option for patients undergoing pelvic radiotherapy to mitigate vaginal stenosis. ...OBJECTIVES: We conducted a systematic literature review to find information to guide clinical recommendations to pelvic radiotherapy patients on p …
Dilator therapy is an option for patients undergoing pelvic radiotherapy to mitigate vaginal stenosis. ...OBJECTIVES: We condu …
The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
Kershaw V, Hickey I, Wyld L, Jha S. Kershaw V, et al. Eur J Obstet Gynecol Reprod Biol. 2021 Oct;265:7-17. doi: 10.1016/j.ejogrb.2021.08.001. Epub 2021 Aug 8. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 34416580 Review.
This reduces the risk of ovarian cancer by up to 96%, but can result in undesirable side effects, including menopausal symptoms and sexual dysfunction. ...Comprehensive pre-operative counselling regarding anticipated menopausal and sexual symptoms is key to setting realist …
This reduces the risk of ovarian cancer by up to 96%, but can result in undesirable side effects, including menopausal symptoms and s …
Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
Ong KJ, Checchi M, Burns L, Pavitt C, Postma MJ, Jit M. Ong KJ, et al. Sex Transm Infect. 2019 Feb;95(1):28-35. doi: 10.1136/sextrans-2018-053606. Epub 2018 Sep 21. Sex Transm Infect. 2019. PMID: 30674687
Cost per case ranges were US$124-US$883 (anogenital warts), US$6912-US$52 579 (head and neck cancers), US$12 936-US$51 571 (anal cancer), US$17 524-34 258 (vaginal cancer), US$14 686-US$28 502 (vulvar cancer) and US$9975-US$27 629 (penile cancer
Cost per case ranges were US$124-US$883 (anogenital warts), US$6912-US$52 579 (head and neck cancers), US$12 936-US$51 571 (anal cancer
38 results